MAFG Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O15525 |
---|---|
Clone Names | 100712055 |
Gene ID | 4097 |
---|---|
Other Names | Transcription factor MafG, V-maf musculoaponeurotic fibrosarcoma oncogene homolog G, hMAF, MAFG |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | MAFG |
---|---|
Function | Since they lack a putative transactivation domain, the small Mafs behave as transcriptional repressors when they dimerize among themselves (PubMed:11154691). However, they seem to serve as transcriptional activators by dimerizing with other (usually larger) basic-zipper proteins, such as NFE2, NFE2L1 and NFE2L2, and recruiting them to specific DNA-binding sites (PubMed:8932385, PubMed:9421508, PubMed:11154691). Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NFE2L2 transcription factor (PubMed:11154691). Transcription factor, component of erythroid- specific transcription factor NFE2L2 (PubMed:11154691). Activates globin gene expression when associated with NFE2L2 (PubMed:11154691). May be involved in signal transduction of extracellular H(+) (By similarity). |
Cellular Location | Nucleus {ECO:0000255|PROSITE-ProRule:PRU00978, ECO:0000269|PubMed:11154691} |
Tissue Location | Highly expressed in skeletal muscle. Also expressed in heart and brain |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Globin gene expression is regulated through nuclear factorerythroid-2 (NFE2) elements located in enhancer-like locus controlregions positioned many kb upstream of alpha- and beta-geneclusters (summarized by Blank et al., 1997 [PubMed 9166829]). NFE2DNA-binding activity consists of a heterodimer containing aubiquitous small Maf protein (MafF, MIM 604877; MafG; or MafK, MIM600197) and the tissue-restricted protein p45 NFE2 (MIM 601490).Both subunits are members of the activator protein-1-likesuperfamily of basic leucine zipper (bZIP) proteins (see MIM165160).
References
Wang, X., et al. PLoS ONE 5 (8), E11934 (2010) :Berg, D.T., et al. J. Biol. Chem. 282(51):36837-36844(2007)Yamamoto, T., et al. Genes Cells 11(6):575-591(2006)Stelzl, U., et al. Cell 122(6):957-968(2005)Tramier, M., et al. Biophys. J. 83(6):3570-3577(2002)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.